Functional vascularized lung grafts for lung bioengineering

End-stage lung disease is the third leading cause of death worldwide, accounting for 400,000 deaths per year in the United States alone. To reduce the morbidity and mortality associated with lung disease, new therapeutic strategies aimed at promoting lung repair and increasing the number of donor lu...

Descripción completa

Detalles Bibliográficos
Autores principales: Dorrello, N. Valerio, Guenthart, Brandon A., O’Neill, John D., Kim, Jinho, Cunningham, Katherine, Chen, Ya-Wen, Biscotti, Mauer, Swayne, Theresa, Wobma, Holly M., Huang, Sarah X. L., Snoeck, Hans-Willem, Bacchetta, Matthew, Vunjak-Novakovic, Gordana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2017
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5576878/
https://www.ncbi.nlm.nih.gov/pubmed/28875163
http://dx.doi.org/10.1126/sciadv.1700521

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5576878/
https://www.ncbi.nlm.nih.gov/pubmed/28875163
http://dx.doi.org/10.1126/sciadv.1700521

Ejemplares similares